Get started
Author

Carla Gerber

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
2024 · Cassandra M J Wannan, Barnaby Nelson, et al. · Schizophrenia Bulletin · 97
PDF
Digital Trajectories to Care in First-Episode Psychosis
2018 · Michael L. Birnbaum, Asra F. Rizvi, et al. · Psychiatric Services · 39
PDF
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program
2025 · Johanna T. W. Wigman, Ann Ee Ching, et al. · Schizophrenia · 17
PDF
Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative
2025 · Zarina R. Bilgrami, Eduardo Castro, et al. · Schizophrenia · 14
PDF
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures
2025 · Daniel H. Mathalon, Spero Nicholas, et al. · Schizophrenia · 14
PDF
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program
2025 · Jean Addington, Lu Liu, et al. · Schizophrenia · 13
PDF
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program
2025 · Michael P. Harms, Kang-Ik K. Cho, et al. · Schizophrenia · 13
PDF
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample
2025 · Kelly Allott, Walid Yassin, et al. · Schizophrenia · 10
Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program
2025 · Jean Addington, Lu Liu, et al. · Schizophrenia Bulletin Open · 6
PDF
The problem of missing data for learning health systems focused on first-episode psychosis
2025 · Delbert G. Robinson, Nina R. Schooler, et al. · Schizophrenia Research · 3
PDF
Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership—Schizophrenia
2025 · Henry R Cowan, Danielle Pratt, et al. · Schizophrenia Bulletin · 2
Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program
2025 · Jean Addington, Amy Shalev, et al. · Schizophrenia Bulletin Open · 1
PDF
External validation and refinement of the Psychosis Polyrisk Score to detect individuals at clinical high risk for psychosis.
2026 · Alameda, Luis, Shenton, Martha E, et al. · UNC Libraries
Positive–affective and negative–cognitive brain–behavior axes in clinical high risk for psychosis
2026 · Sandra Vieira, Yasser Aleman, et al. · Biological Psychiatry
PDF
Unraveling Suicidal Ideation and Behaviors in a Global Cohort of Individuals at Clinical High‐Risk for Psychosis: Multivariable Correlates and Subthreshold Psychotic Symptoms
2026 · Thompson, Judy L., Gerber, Carla, et al. · UNC Libraries
Unraveling Suicidal Ideation and Behaviors in a Global Cohort of Individuals at Clinical High‐Risk for Psychosis: Multivariable Correlates and Subthreshold Psychotic Symptoms
2026 · Stefano Damiani, Marika Orlandi, et al. · Acta Psychiatrica Scandinavica
PDF
External validation and refinement of the Psychosis Polyrisk Score to detect individuals at clinical high risk for psychosis
2026 · Riccardo Stefanelli, Dominic Oliver, et al. · BMJ Mental Health
PDF
The Dynamics of Psychopathology, Cognitive Performance and Functioning in Individuals at Clinical High Risk for Psychosis: A Network Analysis of Ambulatory Assessments in a Prospective Longitudinal Cohort (Preprint)
2026 · Hannah Hacker, Jessica A. Hartmann, et al. · JMIR Mental Health
Relationship among Sleep Disturbance, Stress, and Suicidal Ideation in Clinical High Risk for Psychosis
2026 · Heather M Wastler, Aubrey Moe, et al. · Schizophrenia Bulletin Open
PDF
Works count: 20
Citation count: 229
H-index: 8
I10-index: 8
Year
Topic
Type